Compare YOU & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YOU | BLCO |
|---|---|---|
| Founded | 2010 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.4B |
| IPO Year | 2021 | 2022 |
| Metric | YOU | BLCO |
|---|---|---|
| Price | $55.03 | $16.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $50.29 | $18.45 |
| AVG Volume (30 Days) | ★ 1.3M | 426.6K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $900,779,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $17.56 | $8.65 |
| Revenue Next Year | $14.73 | $5.59 |
| P/E Ratio | $20.59 | ★ N/A |
| Revenue Growth | ★ 16.91 | 6.47 |
| 52 Week Low | $27.23 | $12.41 |
| 52 Week High | $62.73 | $18.92 |
| Indicator | YOU | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 53.69 | 63.89 |
| Support Level | $54.24 | $14.62 |
| Resistance Level | $55.64 | $16.54 |
| Average True Range (ATR) | 2.20 | 0.43 |
| MACD | 0.21 | 0.14 |
| Stochastic Oscillator | 88.14 | 77.94 |
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in creating a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports, helping to make the travel experience safe and easy. The Company's operations are mainly focused on growing and maintaining its secure identity network across multiple offerings in both aviation and non-aviation channels.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.